甲诺尼丁:药理性质和治疗潜力
1University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India.
一种天然的异黄类化合物 - - 甲诺丁 (Formononetin) 对各种疾病具有治疗潜力,具有良好的药理动力学. 提高其交付和探索衍生品可以提高临床使用和疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 福莫诺尼丁 (FMN) 是一种植物衍生的异黄,具有已证明的治疗效果.
- 它可以在Trifolium pratense和Astragalus membranaceus等植物中找到.
- FMN在神经系统疾病,癌症,炎症和代谢疾病方面表现有前途.
研究的目的:
- 在各种疾病模型中审查formononetin的药理潜力.
- 为了突出其药理动力学和安全性的最新进展.
- 探索提高其治疗疗效和临床适用性的策略.
主要方法:
- 在体内和体外研究的文献综述.
- 对血管健康,骨密度和葡萄糖代谢的临床试验数据的分析.
- 检查药物动力学数据,包括吸收,新陈代谢和半衰期.
主要成果:
- 甲米诺尼丁呈现出快速的口服吸收和短半衰期,由肝酶调节.
- 它的疗效可以通过衍生物形成或组合疗法来提高.
- 纳米配方和化学修饰显示出增强生物可用性的前景.
结论:
- 福莫诺尼丁具有显著的治疗潜力,但需要进一步研究.
- 下一代交付系统和衍生合成是改善临床应用的关键.
- 需要进行全面的毒理学研究来确保长期的安全性.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Cholinergic Antagonists: Pharmacokinetics
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
